Монголын Анагаахын Сэтгүүлүүдийн Холбоо (МАСХ)
Mongolian Journal of Health Sciences, 2007, 1(4)
Visual inspection with acetic acid in the early Detection of cervical cancer and precursors in mongolia
( Судалгааны өгүүлэл )

Lkhagvajargal G.'2, BaigalG.1, Erdenejargal A.', AvirmedD.'-', JavB.2

'National Cancer Center of Mongolia 2 School of Medicine, Health Sciences University of Mongolia

 
Абстракт

To evaluate the test parameters of VIA and cervical cytology in 3 Mongolian aimags. From 18 Feb2002 to 12Dec 2004, sexually active women, 30 years or older who had been screened underwent cervical cytology and VIA in the aimags central hospital. All women with abnormal test results and 5% of women with normal results underwent colposcopy with or without biopsy. 2009 women underwent both tests. VIA was abnormal in 254 (12.6%); half did not attend the colposcopy assessment Pap smear showed ASCUS or worse in 3%; 2 patients with HSIL or worse did not return for colposcopy. Of those normal asked to attend colposcopy, 44% attended. Using CIN2 or higher disease on biopsy as the end point, the parameters for VIAA are sensitivity 82.9%, specificity 88.6%, PPV 12.2% NPV 99.7%. The test parameters for Pap smear are sensitivity 88.6%, specificity 98.5% PPV 51.7%, and NPV 99.8%. VIA has acceptable test parameter for population based cervical screening in Mongolia. It is concerning that compliance with colposcopy was only 50%. Thus a method of immediate colposcopy or see and treat is required in this study.

Ном зүй

1. Royal Thai College of obstetrician and Gynecologist (RTCOG), JHPIEGO. Safety, acceptability and feasibility of a single-visit approach to cervical-cancer
prevention in rural Thailand: a demonstration project. Lancet 2003; pp.814-820
2. IARC. GLOBOCAN 2000 - Cancer incidence, Mortality and prevalence Worldwide. 2000; IARC. France, pp. http: //www-dep. iarc
3. Kitchener HC, Symonds P. Detection of cervical intraepithelial neoplasia in developing countries. Lancet \\ 999; pp.856-857
4. Kurman RJ, Solomon D, editors. The Bethesda System for reporting cervical/vaginal cytologic diagnosis. New York: Springer-Verlag, 1994; The Bethesda
System for reporting cervical/vaginal cytologic diagnosis, pp.56-74
5. Denny L, Kuhn L, Richart R, et al. Two-stage cervical cancer screening: An alternative for resource-poor settings. Am J Obstet Gynecol 2000; pp.383-388
6. Gaffikin L, Lauterbach M, Blumenthal P. Performance of Visual Inspection with acetic acid for cervical cancer screening: A qualitative summary of evidence to
date. Obstetrical and Gynecological Survey. 2003;58 pp.543-550
7. Belinson J.L, Qiao Y. L., Pretorius R, et al. Province Cervical cancer screening study; A cross-sectional comrarative trial of multiple techniques to detect
cervical neoplasia. Gynecol Oncol 2001; 83,pp.439-444
8. Rodrigues-Reyes er, Cerda-Flores RM, Quinonez-perez JM, et al. Acetic Acid Test: A promising screening test for early detection of cervical cancer. Analyt
Quant Cytol Hislol 2002; pp. 134-136
9. Basu PS, Sankaranarayanan R, Dal R, Roy C, et al. Visual Inspection with acetic acid and cytology in the early
detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer. 2003;pp.626-632
lO.Wu LY, Li N, Zhang WH, Li L, et al. Value of acetic acid smear test for cervical cancer screening. Ai Zhing 2003; 22: pp.1096-1098

 


Зохиогчийн оруулсан түлхүүр үгс


Нийтлэлийн нээгдсэн тоо: 290
Судлаачдын бусад өгүүлэл
Зохиогчийн эрх хуулиар хамгаалагдсан. Дэлхийн Эрүүл Мэндийн Байгууллага, ©  2012.
Вебийг бүтээсэн Слайд ХХК